IGFBP7 and acute kidney injury: In the study, the authors tried to identify patients who were at a high risk for CSA-AKI by combining clinical risk stratification with either the CCS and LS and the early postoperative quantification of urinary biomarkers for AKI using (TIMP-2)·(IGFBP7).